Epilepsy Research
Volume 23, Issue 2 , Pages 95-104 , March 1996

Effect of para-aminohippurate on the efflux of valproic acid from the central nervous system of the rabbit

  • Kimberly D.K. Adkison

      Affiliations

    • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA
    • Glaxo Wellcome Research Institute, Five Moore Drive, Research Triangle Park, NC, USA
    • ,
  • Karen M. Powers

      Affiliations

    • Department of Anesthesiology, School of Medicine, University of Washington, Seattle, WA, USA
    • ,
  • Alan A. Artru

      Affiliations

    • Corresponding Author InformationCorresponding author. Dept. of Anesthesiology, University of Washington, 1959 NE Pacific St., Box 356540, Seattle, WA 98195-6540, USA. Tel.: (206) 685-2071; fax: (206) 543-2958
    • Department of Anesthesiology, School of Medicine, University of Washington, Seattle, WA, USA
    • ,
  • Danny D. Shen

      Affiliations

    • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA, USA

Received 15 September 1995 ,Accepted 29 September 1995.

References 

  1. Shen DD, Ojemann GA, Rapport RL, Dills RL, Friel PN, Levy RH. Low and variable presence of valproic acid in human brain. Neurology. 1992;42:582–585
  2. Nau H, Löscher W. Valproic acid: Brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse. J. Pharmacol. Exp. Ther. 1982;220:654–659
  3. Hammond EJ, Perchalski RJ, Villarreal HJ, Wilder BJ. In vivo uptake of valproic acid in brain. Brain Res. 1982;240:195–198
  4. Löscher W, Nau H. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment. J. Pharmacol. Exp. Ther. 1983;226:845–854
  5. Ichimura F, Deguchi Y, Yokogama K, Yamana T. Physiologically based pharmacokinetics of valproic acid in rabbits. Int. J. Pharm. 1985;27:45–60
  6. Lockard JS, Viswanathan CT, Levy RH. Diurnal oscillations of CSF valproate in monkey. Life Sci. 1985;36:1281–1285
  7. Semmes RLO, Shen DD. Comparative pharmacodynamics and brain distribution of E-Δ2-valproate and valproate in rats. Epilepsia. 1991;32:232–241
  8. MacMillan V, Leake J, Chung T, Bovell M. The effect of valproic acid on the 5-hydroxyindoleacetic, homovanillic and lactic acid levels of cerebrospinal fluid. Brain Res. 1987;420:268–276
  9. Frey HH, Löscher W. Distribution of valproate across the interface between blood and cerebrospinal fluid. Neurol. Pharmacol. 1978;17:637–642
  10. Adkison KDK, Artru AA, Powers KM, Shen DD. Contribution of probenecid-sensitive anion transport processes at the choroidal epithelium and brain capillary endothelium to the efficient removal of valproic acid from the CNS. J. Pharmacol. Exp. Ther. 1994;268:797–805
  11. Adkison KDK, Shen DD. Uptake of valproic acid into rat brain is mediated by a medium- and long-chain fatty acid transporter. J. Pharmacol. Exp. Ther. 1995; submitted
  12. Baramy EH. Inhibition by hippurate and probenecid of in vitro uptake of iodipamide and O-iodohippurate: A composite uptake system for iodipamide in choroid plexus, kidney cortex and anterior uvea of several species. Acta Physiol. Scand. 1972;86:12–27
  13. Fishman RA. Blood-brain and CSF barriers to penicillin and related organic acids. Arch. Neurol. 1966;15:113–124
  14. Domer FR. Drug inhibition of PAH transport from cerebrospinal fluid in rabbits. Exp. Neurol. 1973;40:414–423
  15. Spector R, Lorenzo AV. The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicyclic acid and iodide. J. Pharmacol. Exp. Ther. 1974;188:55–65
  16. Dacey RG, Sande MA. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 1974;6:437–441
  17. Spector R. Ceftriaxone pharmacokinetics in the central nervous system. J. Pharmacol. Exp. Ther. 1986;236:380–383
  18. Artru AA. Cerebrospinal fluid. In:  Cottrell JE,  Smith DS editor. Anesthesia and Neurosurgery. St. Louis: Mosby-Year Book, Inc; 1994;p. 93–116
  19. Burckhardt G, Ullrich KJ. Organic anion transport across the contraluminal membrane-dependence on sodium. Kidney Int. 1989;36:370–377
  20. Foxworthy JC, Artru AA. Cerebrospinal fluid dynamics and brain tissue composition following intravenous infusions of hypertonic saline in anesthetized rabbits. J. Neurosurg. Anesthesiol. 1990;2:256–265
  21. Gregory TK, Pettus DC. An electroencephalographic processing algorithm specifically intended for analysis of cerebral electrical activity. J. Clin. Monit. 1986;2:190–197
  22. Smith NT, Westover CJ, Quinn M, Benthuysen JL, Silver HD, Sanford TJ. An electroencephalographic comparison of alfentanil with other narcotics and with thiopental. J. Clin. Monit. 1985;1:236–244
  23. Davson H. Chemical composition and secretory nature of fluids. In:  Davson H editors. Physiology of the Cerebrospinal Fluid. Boston: Little, Brown Company; 1970;p. 35–54
  24. Semmes RLO, Shen DD. Capillary gas chromatographic assay for valproic acid and its 2-desaturated metabolite in brain and plasma. J. Chromatogr. 1986;432:185–197
  25. Heisey SR, Held D, Pappenheimer JR. Bulk flow and diffusion in the cerebrospinal fluid system of the goat. Am. J. Physiol. 1962;203:775–781
  26. Pollay M, Davson H. The passage of certain substances out of the cerebrospinal fluid. Brain. 1963;86:137–150
  27. Kuo J, Fox E, McDonald S. Comparing two or more groups. In: fourth edition.  Kuo J,  Fox E,  McDonald S editor. SigmaStat Users Manual. San Rafael: Jandel Scientific; 1992;p. 6dash1–6dash80
  28. Naora K, Shen DD. Uptake of valproic acid by isolated rat brain microvessels. Pharm. Res. 1994;11:S203
  29. Werdinius B. Effect of probenecid on the levels of monoamine metabolites in the rat brain. Acta Pharmacol. Toxicol. 1967;25:18–23
  30. Andersson H, Von Essen C, Roos BE. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid after intrathecal and intravenous administration of probenecid to normal and hydrocephalic dogs. Acta Pharmacol. Toxicol. 1973;32:139–147
  31. Vogt M. Metabolites of cerebral transmitters entering the cerebrospinal fluid; their value as indicators of brain function. In:  Cserr HF,  Fenstermacher JD,  Fencl V editor. Fluid Environment of the Brain. New York: Academic Press; 1975;p. 225–236
  32. Dixon RL, Owens ES, Rall DP. Evidence of active transport of benzyl-14C-penicillin from cerebrospinal fluid to blood. J. Pharm. Sci. 1969;58:1106–1109
  33. Suzuki H, Sawada Y, Sugiyama Y, Iga T, Hanano M. Transport of benzylpenicillin transport in rat choroid plexus. J. Pharmacol. Exp. Ther. 1987;243:1147–1152
  34. Bidiville J, Roch-Ramel F. Competition of organic anions for furosemide and p-aminohippurate secretion in the rabbit. J. Pharmacol. Exp. Ther. 1986;237:636–643
  35. Adkison KDK, Artru AA, Powers KM, Shen DD, Nochlin D. Role of choroid plexus and brain capillary endothelium in the efflux of valproic acid from the central nervous system of the rabbit. Epilepsy Res. 1995;20:185–192

PII: 0920-1211(95)00092-5

Epilepsy Research
Volume 23, Issue 2 , Pages 95-104 , March 1996

Article Tools